In the BioHarmony Drug Report Database
Capecitabine
Xeloda (capecitabine) is a small molecule pharmaceutical. Capecitabine was first approved as Xeloda on 1998-04-30. It is used to treat breast neoplasms and colorectal neoplasms in the USA. It has been approved in Europe to treat breast neoplasms, colonic neoplasms, colorectal neoplasms, and stomach neoplasms. The pharmaceutical is active against thymidylate synthase.
Trade Name
|
Xeloda |
|---|---|
Common Name
|
capecitabine |
ChEMBL ID
|
CHEMBL1773 |
Indication
|
breast neoplasms, colonic neoplasms, colorectal neoplasms, stomach neoplasms |
Drug Class
|
Nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives |
Image (chem structure or protein)